PPP6C and neoplasm: All mutations found in the biopsy of P19 were verified in plasma, including a missense mutation of the putative tumour suppressor PPP6C (p.R264C)26 that is sensitive to Aurora Kinase inhibition27 (Supplementary Table 6, Fig. 7).